# United States 12 Month Natural Gas Fund, LP: financial statements, quarterly

UNL · NYSE · CIK 1405513 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/unl.md) · [Financials](/companies/unl/financials.md) · [Filings](/companies/unl/filings.md) · [Insiders](/companies/unl/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/unl/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [(882)](/filings/0001410578-25-000266.md) | [(4,544)](/filings/0001410578-25-000266.md) | [(2,240)](/filings/0001104659-26-023411.md) | [1,257](/filings/0001104659-26-023411.md) | [(494)](/filings/0001104659-26-023411.md) | [552](/filings/0001104659-26-023411.md) | [4,244](/filings/0001104659-26-057784.md) | [(2,332)](/filings/0001104659-26-092634.md) | [(1,284)](/filings/0001104659-26-023411.md) | [(1,364)](/filings/0001104659-26-023411.md) | [(594)](/filings/0001104659-26-057784.md) | [(1,022)](/filings/0001104659-26-092634.md) |
| Net income | $k | [(921)](/filings/0001410578-25-000266.md) | [(4,588)](/filings/0001410578-25-000266.md) | [(2,278)](/filings/0001104659-26-023411.md) | [1,178](/filings/0001104659-26-023411.md) | [(596)](/filings/0001104659-26-023411.md) | [477](/filings/0001104659-26-023411.md) | [4,185](/filings/0001104659-26-057784.md) | [(2,383)](/filings/0001104659-26-092634.md) | [(1,348)](/filings/0001104659-26-023411.md) | [(1,425)](/filings/0001104659-26-023411.md) | [(660)](/filings/0001104659-26-057784.md) | [(1,105)](/filings/0001104659-26-092634.md) |

- Revenue: us-gaap:Revenues
- Net income: us-gaap:NetIncomeLoss

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [14.3](/filings/0001410578-24-001822.md) | [14.5](/filings/0001104659-26-023411.md) | [15.1](/filings/0001410578-25-001162.md) | [17.3](/filings/0001410578-25-001637.md) | [18.6](/filings/0001104659-25-108393.md) | [17.9](/filings/0001104659-26-023411.md) | [15.0](/filings/0001104659-26-057784.md) | [11.8](/filings/0001104659-26-092634.md) | [9.6](/filings/0001104659-25-108393.md) | [18.2](/filings/0001104659-26-092634.md) | [14.4](/filings/0001104659-26-057784.md) | [15.7](/filings/0001104659-26-092634.md) |
| Total assets | $m | [16.9](/filings/0001410578-23-002208.md) | [16.4](/filings/0001410578-25-000266.md) | [17.2](/filings/0001410578-24-000693.md) | [18.8](/filings/0001410578-24-001234.md) | [20.3](/filings/0001410578-24-001822.md) | [19.0](/filings/0001104659-26-023411.md) | [18.4](/filings/0001410578-25-001162.md) | [12.3](/filings/0001410578-25-001637.md) | [10.5](/filings/0001104659-25-108393.md) | [18.8](/filings/0001104659-26-092634.md) | [15.6](/filings/0001104659-26-057784.md) | [17.4](/filings/0001104659-26-092634.md) |
| Total liabilities | $m | [0.1](/filings/0001410578-23-002208.md) | [0.1](/filings/0001410578-25-000266.md) | [0.1](/filings/0001410578-24-000693.md) | [0.6](/filings/0001410578-24-001234.md) | [0.1](/filings/0001410578-24-001822.md) | [0.4](/filings/0001104659-26-023411.md) | [2.0](/filings/0001410578-25-001162.md) | [0.1](/filings/0001410578-25-001637.md) | [0.1](/filings/0001104659-25-108393.md) | [0.1](/filings/0001104659-26-092634.md) | [0.1](/filings/0001104659-26-057784.md) | [0.1](/filings/0001104659-26-092634.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,928) d](/filings/0001410578-24-001822.md) | [(2,708) d](/filings/0001104659-26-023411.md) | [(4,661)](/filings/0001410578-25-001162.md) | [111 d](/filings/0001410578-25-001637.md) | [(1,321) d](/filings/0001104659-25-108393.md) | [(456) d](/filings/0001104659-26-023411.md) | [3,587](/filings/0001104659-26-057784.md) | [(1,337) d](/filings/0001104659-26-092634.md) | [(128) d](/filings/0001104659-25-108393.md) | [(170) d](/filings/0001104659-26-023411.md) | [(1,124)](/filings/0001104659-26-057784.md) | [(1,132) d](/filings/0001104659-26-092634.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities

Shares outstanding: 2,700,000 at 2026-08-04, from the cover of the [10-Q filed 2026-08-07](/filings/0001104659-26-092634.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.